This reply
Pei-Chi Lo mark this message contains personal perspective
originally written by Pei-Chi Lo
本文主張應採中醫治療乳癌,不應採西醫治療;此與目前國內乳癌治療的「中西醫併治」趨勢不同。

■治療乳癌的西醫用藥的確多有副作用,例如化療藥物小紅莓doxorubicin可能導致心臟衰竭;而依據2019年的研究,搭配使用中藥(如:白花蛇舌草、蒲公英、黃芩、薑黃)可顯著降低心臟衰竭風險。

■國內目前醫界的主流看法,如同上例,認為中醫(不論外用中藥、中藥針劑、口服中醫方劑)在乳癌治療上是擔任「輔助」功能,減輕患者接受西醫療法的副作用,改善生活品質,而並非直接取代西醫治療方式。

Opinion Sources

2019年乳癌患者併用西醫小紅莓、中醫的研究:Traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment:
https://pubmed.ncbi.nlm.nih.gov/30261193/#affiliation-1

臺北市立聯合醫院-乳癌大作戰,中西醫併治,是最佳治療策略:
https://tpech.gov.taipei/mp109181/News_Content.aspx?n=80359412498D4193&sms=D6D8C221F7AECFEE&s=F340A7488DB1C1BF

秀傳醫院-中醫在乳癌防治角色,認為中醫僅為輔助,而非取代西醫:
https://www.scmh.org.tw/dept/breast/edu_ft.htm

高雄榮總-乳癌的中醫調養:
https://wwwfs.vghks.gov.tw/001/VghksUploadFiles/vghks/periodical/pdf/105/1905/105190517.pdf

Traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment - PubMed

Using TCM significantly decreased the incidence of CHF in patients with breast cancer who received conventional chemotherapy with or without radiotherapy.

https://pubmed.ncbi.nlm.nih.gov/30261193/#affiliation-1
The reply is used in the following messages

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.